Entering text into the input field will update the search result below

PTC Therapeutics, Inc. (PTCT) CEO Stuart Peltz on Q1 2021 Results - Earnings Call Transcript

May 06, 2021 1:27 PM ETPTC Therapeutics, Inc. (PTCT)
SA Transcripts profile picture
SA Transcripts

PTC Therapeutics, Inc. (NASDAQ:PTCT) Q1 2021 Results Conference Call May 4, 2021 4:30 PM ET

Company Participants

Kylie O'Keefe - Senior Vice President Commercial and Corporate Strategy

Stuart Peltz - Chief Executive Officer

Matthew Klein - Chief Development Officer

Eric Pauwels - Chief Business Officer

Emily Hill - Chief Financial Officer

Conference Call Participants

Eric Joseph - JP Morgan

Robyn Karnauskas - Truist Securities

Brian Abrahams - RBC Capital Markets

Joseph Thome - Cowen & Company

Colin Bristow - UBS

Sheldon Fan - Barclays

Raju Prasad - William Blair


Ladies and gentlemen, thank you for standing by, and welcome to the PTC First Quarter 2021 Financial Results Conference Call. At this time all participants are in a listen only mode. After the speakers presentation there will be a question-and-answer session. [Operator instructions] Please be advised that today's conference is being recorded. [Operator instructions]

I would now like to hand the conference over to your host, Kylie O'Keefe, Senior Vice President Commercial and Corporate Strategy. Please go ahead.

Kylie O'Keefe

Good afternoon. And thank you for joining us today to discuss the PTC Therapeutics first quarter 2021 corporate update and financial results. Joining me on today's call is our Chief Executive Officer, Stuart Peltz; our Chief Development Officer, Matthew Klein; our Chief Business Officer, Eric Pauwels; and our Chief Financial Officer, Emily Hill. Before we start, let me remind you that today's call will include forward-looking statements based on current expectations. Please take a moment to review this slide posted on our investor relations website in conjunction with the call, which contains our forward-looking statements. Our actual results could materially differ from these forward-looking statements, as any and such risks can materially and adversely affect our business and results of operations.

For a detailed description of applicable risks and uncertainties, we

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.